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AbstrAct
Background The use of the WHO safe surgery checklist 
has been shown to reduce morbidity and mortality from 
surgical procedures. However, whether a WHO-style safe 
procedure checklist can improve safety in the cardiac 
catheterisation laboratory (CCL) has not previously been 
investigated.
Objectives The authors sought to design and implement 
a safe procedure checklist suitable for all CCL procedures, 
and to assess its impact over the course of 1 year.
Methods In the first 3 months, weekly PDSA cycles 
(Plan-Do-Study-Act) were used to optimise the design 
of the checklist through testing and staff feedback, and 
team briefing sessions were introduced before each 
procedure list. The impact of the checklist and team briefs 
was assessed by analysing in-house procedural data 
subsequently submitted to national audit databases. Staff 
and patient questionnaires were performed throughout the 
year.
Results Introduction of the checklist was associated with 
a significant reduction of 3 min in average turnaround 
time (95% CI 25 s to 6 min, p=0.027). Similarly, an initial 
reduction in patient radiation exposure was recorded (dose 
area product reduction of 641.5 cGy/cm2; 95% CI 255.9 to 
1027.1, p=0.002). The rate of reported complications from 
all procedures fell significantly from 2.0% in 2012/2013 
(95% CI 1.6% to 2.4%) to 0.8% in 2013/2014 (95% CI 
0.6% to 1.1%, p≤0.001). Staff climate questionnaires 
showed that technicians and radiographers gave 
more positive responses at the end of the study period 
compared with the beginning (p=0.001).
Conclusions The use of a team brief and WHO-derived 
safe procedure checklist in the CCL was associated 
with decreased radiation exposure, fewer procedural 
complications, faster turnarounds and improved staff 
experience.
Problem
Few medical settings have seen such rapid 
growth in activity over the last two decades as 
the cardiac catheterisation laboratory (CCL). 
Currently in the UK, well over 100 000 percu-
taneous coronary intervention (PCI) proce-
dures are performed annually, in contrast to 
only 10 000 at the turn of the millennium.1 
Moreover, the nature of the procedures 
being undertaken has evolved substantially, 
with newer technologies such as cardiac 
resynchronisation therapy (CRT) devices2 
and transcatheter aortic valve implantation 
(TAVI)3 becoming established. As a result, 
the volume—and complexity—of procedures 
being performed in CCLs has risen dramati-
cally.
However, as the number of procedures 
undertaken in the CCL increases, so does 
the potential for error and patient harm. 
Complex environments such as CCLs—and 
operating theatres—are high-risk areas for 
patient safety incidents (PSIs),4 and compli-
cations during and after percutaneous 
procedures continue to represent a signif-
icant cause of morbidity and mortality.5 In 
comparison with surgical operating theatres, 
the use of specific safety measures in the CCL 
has been relatively understudied, and safety 
reporting metrics remain relatively limited.
Our own organisation is a tertiary referral 
centre for advanced cardiac care located 
in central London; we receive patients 
from all over the UK. We run five catheter-
isation laboratories each day, performing a 
broad variety of complex procedures. This 
requires input from a number of different 
nursing, technical and medical personnel, 
for example, cardiologists, anaesthetists, 
surgeons and paediatricians. However, prior 
to the instigation of this project, we had no 
standardised safety procedures. We noted the 
literature on surgical checklists and felt that 
a similar solution might apply to our cathe-
terisation laboratories. Therefore, our aim 
at the outset was to develop and introduce 
a safe procedure checklist. Our goal was to 
achieve >75% uptake of the checklist over 
the course of the year and to observe the 
impact this had on procedural metrics and 
complications.
background
In the setting of elective non-cardiac surgery, 
safe procedure checklists have been shown 
to prevent complications and errors both 
during the operation and in the periopera-
tive period.6 In particular, the WHO Surgical 
Safety Checklist has been shown to prevent 
morbidity and mortality in a global study7 and 
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in subsequent research.8 9 The WHO checklist is split into 
three distinct phases, incorporating a ‘Sign In’ check of 
essential pre-procedural details, a ‘Time Out’ performed 
immediately before the procedure and a ‘Sign Out’ after 
the procedure to optimise postoperative care. This tripar-
tite format potentially lends itself well to other procedures 
such as those performed in the CCL. Most importantly, a 
checklist serves as a simple way to remind operators of 
actions which—if forgotten—could potentially be life 
threatening.
Although other analyses have been more circumspect 
about the potential benefits of checklists,10 whether a 
WHO-derived checklist can improve safety, efficiency 
and staff experience in the CCL has not previously been 
investigated.
measuremenT
data collection
All checklists were collected and analysed to allow weekly 
assessment of checklist use. Checklists were considered 
incomplete if one or more boxes in any area (Sign In, Time 
Out, Sign Out) had not been marked as done. Procedure 
times were recorded by cardiac technicians using the first 
needle-to-skin or knife-to-skin moment, to the time of final 
vascular access site/wound closure. Radiation exposure 
(screening time and dose area product) was recorded by 
the radiographer involved in the procedure immediately 
after case completion. To assess the impact of the check-
list on other procedural metrics, data were obtained from 
local hospital databases that are compiled and submitted 
to national databases on an annual basis. Data on PCI 
procedure complications were obtained from the informa-
tion submitted to the British Cardiac Intervention Society 
national database, information from which is publicly avail-
able online. Data on complications from electrophysiology 
(EP) procedures were recorded prospectively in a separate 
database submitted to the Central Cardiac Audit Database 
(CCAD), which is audited quarterly by Cardiac Rhythm 
Management (Healthcare Quality Improvement Partner-
ship, UK). Complications from structural heart disease and 
paediatric interventions are also submitted to the CCAD 
for external audit by the Healthcare Quality Improvement 
Partnership. Adverse event reporting was performed using 
Datix online patient safety software (Datix, London, UK).
Patient experience was assessed by questionnaires taken 
at random time points throughout the course of the year 
(see online supplementary information for format of the 
questionnaire); a 10-point Likert scale was used. Staff atti-
tudes towards safety were measured using a standardised 
safety climate survey tool, which has been adapted for use 
in the Royal Brompton since 2010 (see online supple-
mentary information); this survey was administered at the 
beginning of the project, at 7 months and at 12 months, 
and used a 5-point Likert scale.
outcome measures
Outcomes were categorised into three main domains: 
procedural metrics, safety outcomes and staff/patient 
surveys. Metrics of procedural performance included 
average procedure time, turnaround time (the time 
between one case finishing and the following case 
starting, a measure of CCL efficiency), screening time 
and radiation exposure as measured by dose area product 
(DAP). Safety outcomes included the occurrence of any 
major complication during an interventional procedure, 
and the number and severity of adverse incident reports 
submitted via the Trust central reporting system. Major 
complications were defined as follows: cardiac arrest, 
ventricular fibrillation, coronary perforation, heart block 
requiring pacing, cardiac tamponade and vascular access 
complications requiring intervention. Lastly, changes in 
staff safety climate and patient questionnaires (see online 
supplementary information) administered over the 
course of the year were analysed.
baseline data
We collected baseline safety data for the year 2012–2013, 
split into the three main categories of interventional 
procedures we perform. Over the 12-month period, 3.9% 
of EP (eg, pacemakers, ablation) procedures recorded 
complications, compared with 2.4% of percutaneous 
coronary intervention (angioplasty and stenting) proce-
dures and 9.1% of paediatric procedures (eg, septal 
defect closures). Given the complicated nature of the 
procedures performed at our tertiary referral centre, 
these complication rates are difficult to benchmark. 
Nonetheless, it was felt they could be reduced by a more 
structured approach to patient safety in the CCL.
design
We therefore prospectively assessed the impact of the 
introduction of a safe procedure checklist in the CCLs 
at the Royal Brompton Hospital between May 2013 and 
April 2014. The Royal Brompton and Harefield National 
Health Service (NHS) Foundation Trust is a national 
tertiary referral centre for the treatment of heart and 
lung disease, providing a range of elective and emergency 
interventions to adults and children from the UK and 
abroad. At the start of the project, the WHO safe surgery 
checklist was already in use in Trust operating theatres, 
but there were no standardised safety protocols in use in 
the CCLs.
The project was funded by a grant from the Health 
Foundation UK as part of their SHINE programme, 
which was initiated to provide healthcare teams with the 
resources needed to develop and evaluate innovative 
ideas to improve quality of care (http://www. health. org. 
uk/ programmes/ shine- 2012). The funding obtained 
was used to hire a full-time, non-clinical project manager 
(JB) to assist with the day-to-day clinical implementa-
tion of the checklist (ACL, SD) under the guidance of 
the lead clinician for clinical risk (EH). The sponsor 
had no role in the project design, data collection, data 
analysis, data interpretation, or writing of the manu-
script. This Quality Improvement project was approved 
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as part of the Trust Quality Strategy. According to the 
policy activities that constitute research at the Royal 
Brompton and Harefield NHS Trust, this work met 
criteria for operational improvement activities exempt 
from ethics review.
At the outset of the project, our main concern was 
developing a checklist that would be appropriate for the 
procedures carried out in our laboratories (as opposed to 
the surgeries carried out in standard operating theatres). 
We also wanted to ensure our staff used the checklist 
from the outset. Therefore, JB worked closely with the 
study team and laboratory staff from the outset to ensure 
that our checklist was formed and implemented collec-
tively, which we felt was the best way to ensure long-term 
buy-in.
sTraTegy
Our SMART (Specific, Measurable, Attainable, Relevant, 
Timely) goal was to improve patient safety in the CCLs 
of the Royal Brompton hospital by reducing complica-
tion rates by at least 25% from baseline over the course 
of a year. Our initial intervention was to start morning 
team briefs, which were run according to a standardised 
format by the main CCL operator for the day (see online 
supplementary information for format). These continued 
throughout the course of the project.
The checklist project was split into four 3-month PDSA 
cycles (Plan-Do-Study-Act) over the course of 1 year as 
described below:
Pdsa cycle 1
The main goal of the initial 3-month development phase 
was to develop a checklist that was suitable for use by 
all staff, across all procedures performed in our CCLs. 
The WHO safe surgery checklist was initially used as a 
template; however, early consultations with staff identified 
a need for several novel checkboxes, including those for 
antiplatelet drugs and impaired renal function (during 
‘Sign In’, pre-procedural), and notification of high radia-
tion and/or contrast doses (during ‘Sign Out’, postproce-
dural) (figure 1).
During this initial stage of checklist implementation, 
one of the authors (JB) liaised with CCL staff on a weekly 
basis to gather feedback, ensure appropriate use of the 
checklist and to answer any questions on implementa-
tion. By the end of this introductory period, we recorded 
good uptake of the initiative; the checklist was found to 
have been used in 63.9% of cases performed over the 
3-month PDSA cycle.
Pdsa cycle 2
In order to further optimise the checklist and enhance its 
use, we introduced a final ‘ABCD’ (Allergies, Blood Count, 
Figure 1 Final checklist used in the project.
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Clotting, Dye) check to the ‘Time Out’ portion of the 
checklist (figure 1). This was in response to feedback from 
staff that there were four main things that they felt every 
staff member should be aware of prior immediately prior to 
starting a procedure. Despite this, an initial drop in check-
list use—that coincided with the summer months—was 
seen (figure 2). At this stage, we presented our initial results 
at a monthly clinical governance meeting and began to post 
monthly checklist use data at various places in the CCL. As 
a result, by the end of the second PDSA cycle, checklist use 
had increased to 78.8% of cases.
Pdsa cycle 3
Training at monthly clinical governance sessions continued, 
and subsequent to feedback at these meetings, some 
further, minor modifications to the checklist format were 
made. For example, the ‘Sign In’ column was divided into 
‘Patient details’ and ‘Pre Procedure Checks’ sections for 
Figure 2 Checklist use and number of procedures performed each month over the study period.
Figure 3 Turnaround times (the time between a case finishing and the subsequent case starting) were constant in the first 
year. The introduction of checklists (arrow) was associated with a reduction of 3 min 16 s (95% CI 24 s to 6 min 9 s, p=0.027). 
Turnaround time began to decrease by 34 s (95% CI 13 to 55, p=0.003) per month following the introduction of checklists.
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further clarity. By the end of this stage, checklist use had 
increased to 95.1% of all cases.
Pdsa cycle 4
During this period, staff received ongoing training on the 
checklist at monthly clinical governance meetings. During 
this final stage of the project, checklist use remained high 
(>94%; see the Results section below) and no further 
alterations in the checklist format were necessary.
resulTs
checklist development and use
The final checklist is shown in figure 1. During the 
period May 2013–April 2014, the total number of CCL 
procedures performed was 4489, compared with 4502 the 
previous year (May 2012–April 2013). Over the course of 
the year, 3184/4489 completed checklists were returned 
(70.9%). At the end of 3 months (July 2013), checklist use 
Figure 5 Complication rates prior to and during checklist use. Dots, observed rates; line, model estimate. Significant 
reductions in both electrophysiology (EP) (top, p<0.001) and paediatric procedures (bottom, p=0.012) were noted following the 
introduction of the checklist (arrow).
Figure 4 Patient radiation exposure prior to and during checklist use. Dose area product (DAP, cGy/cm2) values were constant 
during the first year. The introduction of checklists (arrow) was associated with a step change in DAP (reduction of 641.5; 95% 
CI 255.9 to 1027.1, p=0.002). DAP began to increase again following the step change and by the end of the second year had 
returned to pre-checklist levels.
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(either complete or incomplete) was 63.9% of cases, after 
6 months 78.8% of cases, after 9 months 95.1% and after 
12 months 94.8% (figure 2).
Procedural metrics
The average monthly procedural time over the year the 
checklist was used was 85.8 min (95% CI 83.4 to 88.4 min). 
There was no significant change in procedure times over 
the course of the project period.
During 2012/2013, turnaround times were constant at 
an average of 29 min (IQR 27 to 30). Average turnaround 
time in 2013/2014 was significantly lower at 21 min (IQR 
20 to 23, p=0.0001). At the introduction of the checklist, 
there was a significant step reduction of 3 min in average 
turnaround time (95% CI 25 s to 6 min, p=0.027). During 
2013/2014, turnaround times continued to fall by an 
average of 34 s per month (95% CI 13 to 55, p=0.003, 
figure 3).
Compared to 2012/2013, average monthly procedure 
screening (X-ray exposure) times during 2013/2014 
decreased from 13.13 (IQR 5.11–20.07) min to 5.32 (IQR 
3.78–8.42) min, but this did not reach statistical signifi-
cance (p=0.106). In contrast, monthly DAP readings 
showed a statistically significant decrease from a mean 
of 2433 cGy/cm2 (95% CI 2318 to 2548) in 2012/2013 
to 2165 cGy/cm2 (95% CI 1917 to 2412) in 2013–2014 
(p=0.042) (figure 4). During 2012/2013, DAP readings 
were constant, but the introduction of the checklist was 
associated with a significant step reduction of 641.5 cGy/
cm2 (95% CI 255 to 1027, p=0.002). Of note, over the 
remainder of the project period, average readings gradu-
ally returned to the same level as before the introduction 
of the checklist (an average increase of 57 cGy/cm2 per 
month (95% CI 10 to 105, p=0.020, figure 4).
safety outcomes
The rate of reported complications from all procedures 
(diagnostic and interventional) was significantly higher 
in 2012/2013 (88/4502; 2.0%; 95% CI 1.6% to 2.4%) 
compared with 2013/2014 (37/4489; 0.8%; 95% CI 0.6% 
to 1.1%, p≤0.001). Of note, there was a step reduction of 
74.6% (95% CI 49.1% to 87.3%, p<0.001) in EP compli-
cations when checklists were introduced (figure 5). 
For paediatric procedures, there was no step change in 
paediatric complication rates at the introduction of the 
checklist; however, complication rates began to fall by an 
average 10.2% per month in 2013/2014 (95% CI 2.3% 
to 17.5%, p=0.012, figure 5). Although PCI complica-
tion rates were lower in 2013/2014 compared with the 
previous year (17/710 (2.4%) compared with 7/789 
(0.9%), p=0.002), there was no step change or change in 
trend at the introduction of checklists.
The mortality rate of all patients undergoing CCL 
procedures in 2013/2014 was lower than in 2012/2013 
(1.0%, 95% CI 0.7% to 1.3% vs 1.2%, 95% CI 0.5% to 
1.0%), but this did not reach statistical significance.
incident reporting
Table 1 shows PSI reporting forms submitted during the 
project year and the preceding year. Overall, there was 
a decrease in the number of incidents reported: 1.62% 
(95% CI 0.89% to 1.54%) of all procedures in 2012/2013 
versus 1.18% (95% CI 1.27% to 2.03%) in 2013/2014 
(p=0.075). No statistically significant difference was seen 
in the severity of incidents reported (p=0.866), although 
there were fewer incidents reported in each of the three 
most severe categories (red 2 vs 0; amber 7 vs 2; yellow 23 
vs 10) during the year of checklist use. Examples of when 
potential adverse incidents were avoided by the checklist 
are shown in box 1.
staff surveys
Over the course of the year following the introduction of 
the checklist, staff were surveyed three times (for specific 
questions, please see online supplementary informa-
tion). There was an increase in the proportion of positive 
Table 1 Patient safety incident form submissions (fewer 
red, amber and yellow forms were submitted in the year 
following checklist introduction; p=0.075)
2012–2013 2013–2014
Red 2 0
Amber 7 2
Yellow 23 10
Green 41 41
Total 73 53
(1.62%; 95% CI 
1.27% to 2.03% of all 
procedures)
(1.18%; 95% CI 
0.89% to 1.54% of all 
procedures)
Colour coding is derived from the UK National Patient Safety 
Agency traffic light system, whereby red, any adverse incident that 
appears to have resulted in permanent harm to, or the death of, 
one or more patients; amber, any adverse incident that resulted 
in a moderate increase in treatment and which caused significant 
but not permanent harm to one or more persons; yellow, any 
adverse incident that required extra observation or minor treatment 
and caused minimal harm to one or more persons; and green, an 
adverse incident that had the potential to cause harm but was 
prevented, resulting in no harm OR any adverse incident that ran to 
completion but no harm occurred.
Box 1 Examples of potential incidents prevented by the 
checklist process
 ► At the Time Out, the operator mentioned the electrical cauterising 
knife he planned to use. The physiologist then alerted him that the 
patient had a hip replacement. The return electrode was reposi-
tioned on the opposite side of the body from the hip replacement.
 ► The patient had a recent pacemaker, which had gone unnoticed. The 
physiologist saw the scar and informed the team at the Time Out, 
causing the operator to change the right heart catheterisation plan.
 ► During the Time Out, the operator stated that he was not aware of 
any allergies, but was informed by the anaesthetist that the patient 
had two. The medication plan was amended to account for this.
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responses (a score of at least 4/5) from technicians/radi-
ographers comparing the first and third surveys (78% 
vs 88%, p=0.001). For nurses, there was no difference 
in the proportion of positive responses (70.1% positive 
responses in both first and third surveys). However, fewer 
nurses reported that they observed errors which could 
delay procedures and increase the risk to patient safety in 
the third compared with first survey (70% vs 30%).
Patient surveys
The overall results of the patient questionnaires are shown 
in table 2. Over the course of the project, 90 patients 
completed surveys. Overall, feelings of safety were high, 
with 83 (92%) rating their feeling of safety at least 8/10.
Moreover, 54/90 (60%) of patients surveyed noticed 
the ‘Time Out’ portion of the checklist during their proce-
dure, and overall this was associated with a strong feeling 
of safety (all but one scored at least 8/10 for feeling safer 
having noticed the ‘Time Out’). Overall, 41/90 (46%) of 
patients surveyed noticed staff following the checklist at 
any stage (‘Sign In’, ‘Time Out’ or ‘Sign Out’), and again 
this was associated with a strong feeling of safety (all but 
two scored at least 8/10). Conversely, those patients who 
did not notice staff following the checklist reported a high 
level of reassurance by the knowledge that a checklist was 
used (44/48 scored at least 8/10). Only 6/90 patients 
were aware of any problems with their procedure; all six 
were in the first half of the surveys.
lessons and limiTaTions
We report here on the impact of the introduction of a 
daily team brief and modified WHO safe procedure 
checklist for interventions taking place in the CCL at a 
tertiary cardiac centre. By engaging and working with all 
CCL staff, a checklist was designed and implemented that, 
when compared with the previous year’s procedures, led 
to faster turnaround between cases, a reduction in radi-
ation exposure, fewer overall procedural complications 
and a trend towards fewer adverse incident reports. As 
a result, high levels of patient and staff satisfaction were 
seen.
While research into patient safety and teamwork in 
the surgical operating theatres has been developing for 
some years,10–12 and checklists have been employed in 
other areas of clinical cardiology,13 14 comparatively little 
work has taken place in the CCL. Cale and Constantino 
performed a literature search to examine the risk factors 
for, and strategies to prevent, complications in the CCL, 
but the authors noted ‘a lack of quality research on this 
subject’.15 Furthermore, the writing committee of a recent 
‘Best Practice in the Cardiac Catheterisation Laboratory’ 
document published by the American Society for Cardio-
vascular Angiography and Interventions acknowledged 
‘a dearth of high-quality published studies’ and recom-
mended further research into quality improvement in 
the CCL.16 A previous study by Gordon et al looked at the 
impact of a checklist in patients who were undergoing 
procedures for structural heart disease, but this was partly 
retrospective, involved far fewer patients and did not use 
the WHO checklist design.17
The design of a checklist for the CCL must account for 
the fact that there are a number of differences between 
procedures performed in the CCL and in theatres. First, 
in the CCL, the volume of procedures tends to be higher, 
with emergency or emergent procedures comprising 
the majority of the workload—especially in hospitals 
performing primary angioplasty. This is significant as 
emergency surgical procedures have been associated 
with more complications that elective operations,18 and 
primary angioplasty is more prone to complications 
than elective cases. Second, the majority of patients who 
undergo procedures in the CCL do so under local anaes-
thesia, and are therefore awake and able to observe the 
functioning of the CCL team. Thirdly, the CCL is the 
setting for multiple professional groups working simulta-
neously; for example, a TAVI procedure may require the 
presence of cardiologists, surgeons, anaesthetists, theatre 
nurses, perfusionists, radiographers and cardiac tech-
nicians.19 Given these important differences, it appears 
logical to amend the existing WHO safe procedure check-
list for use in the CCL. This is also in keeping with the 
WHO recommendation that the safe procedure checklist 
be adapted to local needs.
Table 2 Patient questionnaire results (values are proportion scoring (at least 8/10 or % yes))
Surveys 1–30 Surveys 31–60 Surveys 61–90
How safe did you feel? 27 (90%) 27 (90%) 29 (97%)
Did you notice the time out? 17 (57%) 16 (16%) 21 (70%)
If yes, did you feel safer? 15/16 (94%) 16/16 (100%) 21/21 (100%)
If no, would you have liked to watch it? 8 (67%) 3 (21%) 6 (67%)
Did you see the staff follow the checklist? 16 (53%) 12 (40%) 13 (43%)
If yes, did you feel safer? 14/16 (88%) 10/10 (100%) 13/13 (100%)
If no, does it reassure you to know we use a checklist? 14/14 (100%) 15/18 (83%) 16/17 (94%)
Were you aware of any problems with your procedure? 3 (10%) 3 (10%) 0 (0%)
Was your procedure delayed in any way? 9 (30%) 10 (33%) 6 (20%)
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In conjunction with our staff, we adapted the WHO safe 
surgery checklist over a period of several months while 
simultaneously introducing team briefings. Later in the 
year, we noticed a marked downturn in checklist use over 
the summer months. Regular staff liaison, re-education 
and training were required to ensure the checklist was 
used in a total of 70.9% of cases by the end of the year. A 
number of improvements were subsequently recorded at 
the end of the project.
First, we noted a reduction in turnaround times 
between cases, suggesting that time spent performing the 
checklist may easily be recouped in between procedures. 
In this regard, the ‘Sign Out’ portion of the checklist is 
vital in ensuring patients have a definitive postprocedural 
care plan in place that allows them to be moved out of 
the CCL quickly but safely at the end of the intervention.
Second, we noticed a reduction in radiation exposure 
(as measured by DAP), the cause of which is likely to be 
multifactorial. For example, team briefs and checklist 
procedures should facilitate better communication, and 
thus procedure preparation and planning. In addition, 
lower complication rates (see below) would also reduce 
the need for extended radiation exposure. However, 
it should be noted that by the end of the study period, 
average procedural DAP levels had returned to normal. 
Further research is needed to determine whether this 
represents a limitation of our approach to checklist 
development and implementation, or whether it simply 
reflects the complicated nature of the procedures done 
in our tertiary referral centre.
Thirdly, we noticed fewer major procedural complica-
tions compared with the previous year, and fewer adverse 
incidents were also reported (although this did not 
reach statistical significance). A number of factors could 
contribute to this, including the introduction of the team 
brief, a more regimented ‘Sign In’ than previously used, 
the ‘Time Out’ prior to each procedure and an overall 
improvement in communication between CCL staff. Of 
note, in surgical operating theatres, a relationship has 
been found between communication errors and adverse 
events {Catchpole:2008it}, and both checklists20 and team 
briefings have been shown to improve communication in 
theatres.21
Lastly, our CCL safety climate questionnaire showed 
that our staff felt the CCL was a safer environment as a 
result of checklist use. Recent research has highlighted 
that the methods whereby a checklist is developed and 
introduced may influence its effectiveness,22 and in this 
regard we believe that our decision to assign a specific 
member of the study team (JB) to gain staff feedback on 
checklist design and use was crucial. Of note, we specifi-
cally chose to involve all our laboratory staff in the devel-
opment process and to involve them all in a pilot phase 
prior to full launch. Subsequently, nursing staff noticed 
fewer errors that were likely to lead to patient harm, and 
an increase in positive responses from cardiac technicians 
and radiographers was recorded. Patients also reported 
feeling safer when they noticed the checklist being used. 
Together, these data suggest a general enhancement of 
CCL safety culture over the course of the year and show 
how a checklist and team brief might enhance team 
performance and lead to improved patient experience.
limitations
This study was funded, and a dedicated member of staff 
was hired to be permanently available for staff training 
and education, and also performed instream analysis of 
data. Nonetheless, we feel that our experience—and the 
beneficial outcomes described—are obtainable in any 
cardiac centre, whether or not a dedicated member of 
staff is available. The implementation of morning safe-
ty-briefings and a procedural checklist appeared to cata-
lyse a change in our safety culture that became self-per-
petuating after the checklist format had been finalised.
The Hawthorne effect is a possible limitation of our effi-
ciency and safety measures, in that staff were aware that 
checklists were being collected. However, it is unlikely 
that this contributed directly to the reductions in radi-
ation exposure, complications and turnaround times, as 
staff were not aware of exactly which outcome metrics 
were being measured.
Finally, although several PDSA cycles were used to refine 
our checklist, it still contains a large number of items to 
be checked. A checklist with fewer items would be more 
in keeping with the existing WHO surgical checklist.
conclusion
We have successfully designed and implemented a modi-
fied WHO safe procedural checklist for use in the CCL. 
The checklist was introduced along with morning team 
briefs and was associated with a reduction in patient radia-
tion exposure, improved patient turnaround times, fewer 
procedural complications and an improvement in patient 
and staff experience. Overall, the use of team briefings 
and safe procedural checklists in the CCL appeared to 
be markedly beneficial for the patients and staff of our 
institution, and by the end of the year, checklist use 
remained consistently high. Based on these observations, 
further investigation of catheter laboratory checklists in 
multicentre trials appears warranted. Such trials should 
concentrate on checklist design and also on optimal 
methods of introduction and staff engagement.
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